Skip to main content
SpringerLink
Log in

The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

DBA/2 mice were immunized i.p. against syngeneic SL2 lymphosarcoma cells. At various days after the last immunization peritoneal and spleen lymphocytes were collected. The lymphocyte suspensions were enriched for T-cells by nylon wool filtration.

The peritoneal T-cells from immunized mice (a) expressed direct specific antitumor cytotoxicity in vitro, (b) induced macrophage cytotoxicity in vitro, and (c) exerted tumor neutralization measured in a Winn-type assay. Spleen T-cells from these immunized mice (a) expressed no direct specific antitumor cytotoxicity in vitro, (b) only induced moderate macrophage cytotoxicity in vitro, but (c) exerted tumor neutralization in a Winn assay.

For effective tumor neutralization in vivo effector target cell ratios of 1000:1 were required. When the effector/target ratio of 1000:1 was maintained but the absolute numbers of effector and target cells were lowered from 106 to 105 lymphocytes and 103 to 102 target cells respectively, no tumor neutralization was obtained.

The major effect of the sensitized-transferred T-lymphocytes seemed to be the induction of cytotoxic macrophages in the (naive) recipient mice, as the peritoneal macrophages collected from the recipient mice 7 days after i.p. injection of a mixture of sensitized T-cells and tumor cells were cytotoxic. Purified peritoneal T-lymphocytes collected from these recipient mice were able to induce macrophage cytotoxicity in vitro but expressed no cytotoxic T-cell activity.

In conclusion, our results show that in the tumor system used, tumor neutralization after transfer of sensitized lymphocytes is not dependent on the presence of cytotoxic T-lymphocytes. Lymphocytes with the strongest potency to render macrophages cytotoxic (in vitro and in vivo) also induce the best tumor neutralization in vivo, suggesting an important role for host macrophages as antitumor effector cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carter RH, Drebin JA, Schatten S, Perry LL, Green MI (1983) Regulation of the immune response to tumour antigens. IX. In vitro Lyt 1+2− cell proliferative responses to cell bound or subcellular tumour antigen. J Immunol 130:997

    Google Scholar 

  2. Cheever MA, Greenberg PD, Fefer A (1978) Tumor neutralization, immunotherapy and chemotherapy of a Friend leukemia with cells secondarily sensitized in vitro. II. Comparison of cells cultured with and without tumor to noncultured immune cells. J Immunol 121:2220

    Google Scholar 

  3. De Boer RJ, Hogeweg P, Dullens HFJ, De Weger RA, Den Otter W (1985) Macrophage T-lymphocyte int the anti-tumor immune response: A mathematical model. J Immunol 134:2748

    Google Scholar 

  4. De Jong WH, Van de Plas MMT, Steerenberg PA, Kruizinga W, Ruitenberg EJ (1985) Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10-tumor immunity in straing 2 guinea pigs. J Immunol 134:2032

    Google Scholar 

  5. Den Otter W (1986) Immune surveillance and natural resistance: an evaluation. Cancer Immunol Immunother 21:58

    Google Scholar 

  6. De Weger RA, Den Otter W (1986) Induction of specific macrophage cytotoxicity. Methods Enzymol (in press)

  7. De Weger RA, Pels E, Den Otter W (1982) The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system. Immunology 47:541

    Google Scholar 

  8. De Weger RA, Van Loveren H, De Groot JW, Rangarajan R, Den Otter W (1986) Lymphocytes induce macrophage cytotoxicity. III. Induction of specific macrophage cytotoxicity is independent of lipopolysaccharide. Immunobiology 171:170

    Google Scholar 

  9. Dullens HFJ, Schakenraad S, Oostdyk A, Vuist W, Van der Maas M, Den Otter W (1986) Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes. Cancer Immunol Immunother 22:100

    Google Scholar 

  10. Eberlein TJ, Rosenstein M, Rosenberg SA (1982) Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in Interleukin 2. J Exp Med 156:385

    Google Scholar 

  11. Evans R, Duffy Th (1984) Distribution of tumor sensitized cells during the induction of permanent tumor regression by chemoimmunotherapy: the use of glucose phosphate isomerase as a marker. Int J Cancer 34:575

    Google Scholar 

  12. Evans R, Duffy Th (1985) The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T-cells after chemoimmunotherapy of a murine sarcoma. J Immunol 134:4255

    Google Scholar 

  13. Fernandez-Cruz E, Feldman J (1980) Elimination of syngeneic sarcomas in rats by a subset of T-lymphocytes. J Exp Med 152:823

    Google Scholar 

  14. Fernandez-Cruz E, Woda BA, Feldman JD (1980) Elimination of syngeneic sarcomas in rats by a subset of T-lymphocytes. J Exp Med 152:823

    Google Scholar 

  15. Fernandez-Cruz E, Gilman SC, Feldman JD (1982) Immunotherapy of a chemically-induced sarcoma in rats: Characterization of the effector T-cell subset and nature of suspension. J Immunol 128::1112

    Google Scholar 

  16. Fujiwara H, Fukuzawa M, Yashioka T, Nakajima H, Hamoka T (1984) The role of tumor specific Lyt1+2− T-cells in eradicating tumor cells in vivo. 1. Lyt1+2− T-cells do not necessarily require recruitment of host's cytotoxic T-cell precursors for inplantation of in vivo immunity. J Immunol 133:1671

    Google Scholar 

  17. Gemsa D, Kubelka G, Debatin KM, Krammer PH (1984) Activation of macrophages by lymphokines from T-cell clones: Evidence for different macrophage-activating factors. Mol Immunol 21:1267

    Google Scholar 

  18. Greenberg PhD. Cheever MA, Fefer A (1981) Eradication of disseminated murine leukemia by chemo immunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt1+2− lymphocytes. J Exp Med 154:952

    Google Scholar 

  19. Greenberg Ph, Kern DE, Cheever MA (1985) Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt1+2− T-cells. Tumor eradication does not require participation of cytotoxic T-cells J Exp Med 161:1122

    Google Scholar 

  20. Julius MH, Simpson E, Herzenberg LA (1973) A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 3:645

    Google Scholar 

  21. Leclerc JC, Cantor H (1980) T cell-mediated immunity to oncorna virus-induced tumors. I. Ly-phenotype of precursor and effector cytolytic T-lymphocytes. J Immunol 124:846

    Google Scholar 

  22. Mills CD, North RJ (1983) Expression of passively transferred immunity against an established tumor depends on generation of cytotoxic T-cells in the recipient — Inhibitory T-suppressor cells. J Exp Med 157:1448

    Google Scholar 

  23. Nakajima H, Fujiwara H, Takai Y, Izumi Y, Sano S, Tsuchida T, Hamaoka T (1985). Studies on macrophage activating factor (MAF) in anti-tumor immune responses. I. Tumor-specific Lyt 1+2− T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages. J Immunol 135:2199

    Google Scholar 

  24. Pels E, De Weger RA, Den Otter W (1984) Lymphocyte induced macrophage cytotoxicity: Characterization of the cytotoxicity inducing lymphocyte. Immunobiology 166:84

    Google Scholar 

  25. Romani L, Nardelli B, Bianchi R, Puccetti P, Mage M, Fioretti MC (1985) Adoptive immunotherapy of intracerebral murine lymphomas. Role of different lymphoid populations. Int J Cancer 35:659

    Google Scholar 

  26. Rosenstein M, Eberlein TJ, Rosenberg SA (1984) Adoptive immunotherapy of established syngeneic solid tumors: role of T-lymphoid subpopulations. J Immunol 132:2117

    Google Scholar 

  27. Shimizu K, Shen FW (1979) role of different T-cell sets in the rejection of syngeneic chemically induced tumors. J Immunol 122:1162

    Google Scholar 

  28. Shu S, Steerenberg PA, Hunter JT, Evans CH, Rapp H (1981) Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interaction. Cancer Res 41:3499

    Google Scholar 

  29. Ting CC, Rodrigues D, Igarashi T (1979) Studies of the mechanism for induction of in vivo tumor immunity. III. Recruitment of host helper cell by donor T-cells in adoptive transfer of cell-mediated immunity. J Immunol 122:1510

    Google Scholar 

  30. Van Loveren H, Snoek M, Den Otter W (1982) Host macrophages are involved in systemic adoptive immunity against tumors. Experientia 38:488

    Google Scholar 

  31. Van Loveren H, De Groot JW, Koten JW, Piersma AH, De Weger RA, Den Otter W (1984) A macrophage factor enhancing the systemic antitumor effect of T lymphocytes. Immunobiology 166:118

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rijksuniversiteit Utrecht, Pathologisch Instituut, Pasteurstraat 2, 3511 HX, Utrecht, The Netherlands

    H. F. J. Dullens, W. Vuist, M. Van der Maas & W. Den Otter

Authors
  1. H. F. J. Dullens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Vuist
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Van der Maas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Den Otter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dullens, H.F.J., Vuist, W., Van der Maas, M. et al. The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice. Cancer Immunol Immunother 23, 113–118 (1986). https://doi.org/10.1007/BF00199816

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199816

Keywords

Search

Navigation